Men and women with a range of cancers who took the anti-inflammatory pain killer experienced a “significant” survival benefit compared with those who did not. Researchers analysed data from nearly 14,000 patients in the Netherlands, around half of whom were in the habit of taking aspirin.
Are you up for a challenge?
